Approval · Notice of Compliance 16208 · 2014
TEVA-FINASTERIDE: Notice of Compliance 16208
Issued October 22, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16208
- Date
- October 22, 2014
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Addition of a container closure system
- Therapeutic class
- Type II alpha-reductase inhibitor
- Canadian reference product
- PROSCAR (Merck Frosst Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEVA-FINASTERIDE | Not yet assigned | — |
Medicinal ingredients
- FINASTERIDE 5 MG per TAB